Usefulness of non-high-density lipoprotein cholesterol determinations in the diagnosis and treatment of dyslipidemia

被引：7

作者：

Hirsch, GA

Blumenthal, RS

机构：

[1] Johns Hopkins Ciccarone Prevent Cardiol Ctr, Baltimore, MD USA

[2] NHLBI, NIH, Bethesda, MD 20892 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 91卷 / 07期

关键词：

D O I：

10.1016/S0002-9149(03)00018-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：827 / 830

页数：4

共 30 条

[1] RELATION OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND TRIGLYCERIDES TO INCIDENCE OF ATHEROSCLEROTIC CORONARY-ARTERY DISEASE (THE PROCAM EXPERIENCE) [J].

ASSMANN, G ;

SCHULTE, H .

AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (07) :733-737

[2] Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: Effect of 5 hydroxymethylglutaryl coenzyme a reductase inhibitors on non-high-density lipoprotein cholesterol levels [J].

Ballantyne, CM ;

Andrews, TC ;

Hsia, JA ;

Kramer, JH ;

Shear, C .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (03) :265-269

[3] Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) [J].

Bittner, V ;

Hardison, R ;

Kelsey, SF ;

Weiner, BH ;

Jacobs, AK ;

Sopko, G .

CIRCULATION, 2002, 106 (20) :2537-2542

[4] Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women [J].

Blake, GJ ;

Otvos, JD ;

Rifai, N ;

Ridker, PM .

CIRCULATION, 2002, 106 (15) :1930-1937

[5] Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: A randomized, double-blind, 52-week trial [J].

Brown, WV ;

Bays, HE ;

Hassman, DR ;

McKenney, J ;

Chitra, R ;

Hutchinson, H ;

Miller, E .

AMERICAN HEART JOURNAL, 2002, 144 (06) :1036-1043

[6] Low-density lipoprotein size, pravastatin treatment, and coronary events [J].

Campos, H ;

Moye, LA ;

Glasser, SP ;

Stampfer, MJ ;

Sacks, FM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (12) :1468-1474

[7] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[8]

Cui YD, 2002, ARCH INTERN MED, V162, P109

[9] Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality [J].

Cui, YD ;

Blumenthal, RS ;

Flaws, JA ;

Whiteman, MK ;

Langenberg, P ;

Bachorik, PS ;

Bush, TL .

ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (11) :1413-1419

[10] Serum lipids and incidence of coronary heart disease - Findings from the systolic hypertension in the elderly program (SHEP) [J].

Frost, PH ;

Davis, BR ;

Burlando, AJ ;

Curb, JD ;

Guthrie, GP ;

Isaacsohn, JL ;

WassertheilSmoller, S ;

Wilson, AC ;

Stamler, J .

CIRCULATION, 1996, 94 (10) :2381-2388

← 1 2 3 →